dioscin has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, C; Lu, Q; Lyu, D; Qian, H; Shen, T; Tian, Q; Xi, J; Xiao, P | 1 |
| Cheng, J; Hao, Q; Sun, C; Xue, Y; Zhang, J; Zou, Q | 1 |
2 other study(ies) available for dioscin and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Dioscin Attenuates Myocardial Ischemic/Reperfusion-Induced Cardiac Dysfunction through Suppression of Reactive Oxygen Species.
Topics: Animals; Diosgenin; Humans; Male; Mice; Myocardial Reperfusion Injury; Reactive Oxygen Species | 2021 |
The Protective Effects of Preconditioning With Dioscin on Myocardial Ischemia/Reperfusion-Induced Ventricular Arrhythmias by Increasing Connexin 43 Expression in Rats.
Topics: Animals; Arrhythmias, Cardiac; Biomarkers; Connexin 43; Creatine Kinase, MB Form; Diosgenin; Disease Models, Animal; Heart Rate; Male; Myocardial Reperfusion Injury; Phosphorylation; Protective Agents; Rats, Sprague-Dawley; Tachycardia, Ventricular; Troponin I; Up-Regulation; Ventricular Fibrillation; Ventricular Premature Complexes | 2019 |